SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-115110
Filing Date
2007-05-15
Accepted
2007-05-15 12:42:57
Documents
6
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 183378
2 EMPLOYMENT AGREEMENT dex109.htm EX-10.9 44212
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8398
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8389
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3191
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3276
  Complete submission text file 0001193125-07-115110.txt   252388
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 07850966
SIC: 2834 Pharmaceutical Preparations